Literature DB >> 16702949

Enhanced metastatic dissemination to multiple organs by melanoma and lymphoma cells in timp-3-/- mice.

W Cruz-Munoz1, O H Sanchez, M Di Grappa, J L English, R P Hill, R Khokha.   

Abstract

Identifying versatile inhibitors of metastasis that operate in multiple sites against distinct cancer cell types is important for designing novel therapeutics for metastasis. We show that multiple tissues of timp-3-/- mice are more susceptible to metastatic colonization. Overall, a 5-14-fold increase in liver and kidney colonization occurred by EL-4 lymphoma cells, and a twofold increase upon targeting B16F10 melanoma cells to the bone or lung of timp-3-/- mice. There was a general lack of macrophage or neutrophil localization to metastases in the liver, kidney and lung, and of osteoclasts to bone in both genotypes. Analysis of lung showed that proliferation or angiogenesis were unaltered within the metastatic colonies. Lung-trap assays revealed that initial tumor cell trapping was similar in the lung vasculature of timp-3-/- and wild-type mice. However, more tumor cells were found in timp-3-/- lungs at 48 and 96 h after tumor cell injection indicating more efficient extravasation and initial proliferation. Activation of pro-MMP-2 was greater in timp-3-/- lungs at these time points. These data demonstrate TIMP-3 functions to inhibit metastatic dissemination of diverse cancer cells to multiple organs. TIMP-3 regulates MMP-2 activation to limit tumor cell extravasation and subsequent colonization of the lung, without augmenting inflammatory cell response.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16702949     DOI: 10.1038/sj.onc.1209663

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  Contribution of TIMP3 polymorphisms to the development of preeclampsia in Han Chinese women.

Authors:  Changlong Guo; Xiaofang Cao; Qidi Wang; Guangyu Wang; Lisha An; Meng Du; Yue Qiu; Ying Yang; Hui Li; Yuting Wang; Shuo Wang; Xingyu Wang; Xu Ma
Journal:  J Assist Reprod Genet       Date:  2015-08-25       Impact factor: 3.412

Review 2.  Matrix metalloproteinases and the regulation of tissue remodelling.

Authors:  Andrea Page-McCaw; Andrew J Ewald; Zena Werb
Journal:  Nat Rev Mol Cell Biol       Date:  2007-03       Impact factor: 94.444

Review 3.  Progress in matrix metalloproteinase research.

Authors:  Gillian Murphy; Hideaki Nagase
Journal:  Mol Aspects Med       Date:  2008-05-24

Review 4.  The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity.

Authors:  Keith Brew; Hideaki Nagase
Journal:  Biochim Biophys Acta       Date:  2010-01-15

5.  Tissue inhibitor of metalloproteinase-3 (TIMP3) promotes endothelial apoptosis via a caspase-independent mechanism.

Authors:  Jian Hua Qi; Bela Anand-Apte
Journal:  Apoptosis       Date:  2015-04       Impact factor: 4.677

Review 6.  TIMPs: versatile extracellular regulators in cancer.

Authors:  Hartland W Jackson; Virginie Defamie; Paul Waterhouse; Rama Khokha
Journal:  Nat Rev Cancer       Date:  2016-12-09       Impact factor: 60.716

7.  Monoclonal antibody 4C5 prevents activation of MMP2 and MMP9 by disrupting their interaction with extracellular HSP90 and inhibits formation of metastatic breast cancer cell deposits.

Authors:  Dimitris Stellas; Avraam El Hamidieh; Evangelia Patsavoudi
Journal:  BMC Cell Biol       Date:  2010-07-05       Impact factor: 4.241

8.  MT1-MMP- and Cdc42-dependent signaling co-regulate cell invasion and tunnel formation in 3D collagen matrices.

Authors:  Kevin E Fisher; Anastasia Sacharidou; Amber N Stratman; Anne M Mayo; Sarah B Fisher; Rachel D Mahan; Michael J Davis; George E Davis
Journal:  J Cell Sci       Date:  2009-11-24       Impact factor: 5.285

9.  Overexpression of TACE and TIMP3 mRNA in head and neck cancer: association with tumour development and progression.

Authors:  J-W Kornfeld; S Meder; M Wohlberg; R E Friedrich; T Rau; L Riethdorf; T Löning; K Pantel; S Riethdorf
Journal:  Br J Cancer       Date:  2010-11-23       Impact factor: 7.640

10.  TIMP3 regulates mammary epithelial apoptosis with immune cell recruitment through differential TNF dependence.

Authors:  Carlo V Hojilla; Hartland W Jackson; Rama Khokha
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.